These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37964992)

  • 1. Seroprevalence of SARS-CoV-2 antibodies and associated risk factors during the second wave of infection in a university community in Cameroon.
    Essomba RG; Bayibeki AN; Lissom A; Ateba PT; Seni N; Fouda CAN; Mbitock SBD; Ebonda ND; Afana SD; Akame S; Tembu AA; Ngamaleu MR; Bimai BCB; Kabo O; Nguwoh PS; Ngounouh CT; Meka MCJ; Kengne M; Likeng JN; Kimessoukie EO; Nkoum BA; Assoumou MCO; Fokam J; Yap Boum II; Ambomo MS; Chadou MJP
    Influenza Other Respir Viruses; 2023 Nov; 17(11):e13222. PubMed ID: 37964992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-existing immunity to SARS-CoV-2 before the COVID-19 pandemic era in Cameroon: A comparative analysis according to HIV-status.
    Aissatou A; Fokam J; Semengue ENJ; Takou D; Ka'e AC; Ambe CC; Nka AD; Djupsa SC; Beloumou G; Ciaffi L; Tchouaket MCT; Nayang ARM; Pabo WLT; Essomba RG; Halle EGE; Okomo MC; Bissek AZ; Leke R; Boum Y; Mballa GAE; Montesano C; Perno CF; Colizzi V; Ndjolo A
    Front Immunol; 2023; 14():1155855. PubMed ID: 37090738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective analysis of seroprevalence in a cohort of university students of Rome (Italy) between September 2020 and July 2021.
    Ulivieri A; Morgante A; Magi F; Salehi LB; Lavra L
    Epidemiol Prev; 2022; 46(5-6):367-375. PubMed ID: 36628641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.
    Lone KS; Khan SMS; Qurieshi MA; Majid S; Pandit MI; Haq I; Ahmad J; Bhat AA; Bashir K; Bilquees S; Fazili AB; Hassan M; Jan Y; Kaul RR; Khan ZA; Mushtaq B; Nazir F; Qureshi UA; Raja MW; Rasool M; Asma A; Bhat AA; Chowdri IN; Ismail S; Jeelani A; Kawoosa MF; Khan MA; Khan MS; Kousar R; Lone AA; Nabi S; Qazi TB; Rather RH; Sabah I; Sumji IA
    Front Public Health; 2022; 10():967447. PubMed ID: 36276377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
    Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
    Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Performance of Serological (IgM/IgG) and Molecular Testing (RT-PCR) of COVID-19 in Three Private Universities in Cameroon during the Pandemic.
    Kamga Wouambo R; Djuikoué CI; Esemu LF; Kagoue Simeni LA; Tchitchoua MC; Djouela Djoulako PD; Fokam J; Singwe-Ngandeu M; Mpoudi Ngolé E; Apalata T
    Viruses; 2023 Jan; 15(2):. PubMed ID: 36851621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High seroprevalence of severe acute respiratory syndrome coronavirus 2 among healthcare workers in Yaoundé, Cameroon after the first wave of Covid-19 pandemic and associated factors.
    Tejiokem MC; Abessolo HA; Nkodo JM; Ouethy M; Mayaka GB; Touha Y; Dikoume UA; Tchatchueng-Mbougua JB; Noumbissi DC; Ndjeukam WT; Mbarga HOO; Ngoupo PAT; Moussi C; Garoua BH; Njouom R; Richard V
    Influenza Other Respir Viruses; 2024 Feb; 18(2):e13239. PubMed ID: 38342486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid Increase of Community SARS-CoV-2 Seroprevalence during Second Wave of COVID-19, Yaoundé, Cameroon.
    Ndongo FA; Guichet E; Mimbé ED; Ndié J; Pelloquin R; Varloteaux M; Esemu L; Mpoudi-Etame M; Lamare N; Edoul G; Wouambo RK; Djomsi DM; Tongo M; Tabala FN; Dongmo RK; Diallo MSK; Bouillin J; Thaurignac G; Ayouba A; Peeters M; Delaporte E; Bissek AZ; Mpoudi-Ngolé E
    Emerg Infect Dis; 2022 Jun; 28(6):1233-1236. PubMed ID: 35470795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States.
    Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
    PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Cross-Sectional Study Examining the Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in a University Student Population.
    Tilley K; Ayvazyan V; Martinez L; Nanda N; Kawaguchi ES; O'Gorman M; Conti D; Gauderman WJ; Van Orman S
    J Adolesc Health; 2020 Dec; 67(6):763-768. PubMed ID: 33071164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.
    Charlton CL; Nguyen LT; Bailey A; Fenton J; Plitt SS; Marohn C; Lau C; Hinshaw D; Lutsiak C; Simmonds K; Kanji JN; Zelyas N; Lee N; Mengel M; Tipples G
    Microbiol Spectr; 2021 Sep; 9(1):e0029121. PubMed ID: 34406813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of SARS-CoV-2-specific antibodies in cancer outpatients in Madrid (Spain): A single center, prospective, cohort study and a review of available data.
    Cabezón-Gutiérrez L; Custodio-Cabello S; Palka-Kotlowska M; Oliveros-Acebes E; García-Navarro MJ; Khosravi-Shahi P
    Cancer Treat Rev; 2020 Nov; 90():102102. PubMed ID: 32947121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of SARS-CoV-2 in 10 Regional Capitals of Cameroon, October-December 2020.
    Sachathep K; Duong YT; Reid G; Dokubo EK; Shang JD; Ndongmo CB; Gabriel E; Tharp G; Dimite LE; N'Dir A; Okpu G; Ogollah FM; Nguafack D; Ntse MC; Hrusa G; Yuengling K; Tebbenhoff M; René E; Françoise NS; Felicity NT; Okomo MC; Bissek AZ; Harris TG
    Influenza Other Respir Viruses; 2024 Apr; 18(4):e13267. PubMed ID: 38532666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence and characteristics of Coronavirus Disease (COVID-19) in workers with non-specific disease symptoms.
    Javed W; Abidi SHB; Baqar JB
    BMC Infect Dis; 2022 May; 22(1):481. PubMed ID: 35596145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of antibodies against SARS-CoV-2 in the school community in Campo Grande, state of Mato Grosso do Sul, Brazil, October 2021-November 2022.
    Stutz C; Alcantara DMC; Dos Santos CM; Torres JM; Rodrigues R; Marcon GEB; Ferreira EC; Sarti ECFB; de Oliveira TF; Mendes FML; Lemos EF; Demarchi LHF; Lichs GGC; Zardin MCSU; Gonçalves CCM; Guilhermino JF; Perdomo RT; Fernandez ZDC
    Front Immunol; 2024; 15():1354786. PubMed ID: 38596680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.
    Caban-Martinez AJ; Schaefer-Solle N; Santiago K; Louzado-Feliciano P; Brotons A; Gonzalez M; Issenberg SB; Kobetz E
    Occup Environ Med; 2020 Dec; 77(12):857-861. PubMed ID: 32764107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
    Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
    JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of SARS -CoV-2 IgG/IgM antibodies among patients in Zakho City, Kurdistan, Iraq.
    Saeed AY; Assafi MS; Othman HE; Shukri HM
    J Infect Dev Ctries; 2022 Jul; 16(7):1126-1130. PubMed ID: 35905016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.